par Muylle, Kristoff ;Castaigne, Catherine ;Flamen, Patrick
Référence Current opinion in oncology, 17, 3, page (249-253)
Publication Publié, 2005-05
Référence Current opinion in oncology, 17, 3, page (249-253)
Publication Publié, 2005-05
Article révisé par les pairs
Résumé : | Positron emission tomography using 18F-fluoro-2-deoxy-D-glucose (18FDG-PET) is well established in clinical routine as a metabolism-based whole-body imaging tool for cancer diagnosis and follow-up. Several reports have appeared indicating the potential and limitations of this technique in head and neck cancer (HNC). This review limits its scope to the recent advances using 18FDG-PET in the clinical management of HNC. |